3039 |
OCT-Guided BRS Implantation |
Yoshinobu Onuma |
Apr. 21. 16 |
3038 |
Impact of OCT- vs. IVUS-Guided PCI: OPINION and ILUMIEN |
Takashi Akasaka |
Apr. 21. 16 |
3037 |
Impact of IVUS- vs. Angiography-Guided PCI: IVUS-XPL |
Myeong-Ki Hong |
Apr. 21. 16 |
3036 |
Imaging Criteria for DES Optimization |
Gary S. Mintz |
Apr. 21. 16 |
3035 |
PCSK9 Inhibitors & Beyond the Limits: Why Reducing LDL-C Matters? |
Ki Hoon Han |
Apr. 21. 16 |
3034 |
Risk of Recurrence in ACS: Why They Happen and How to Stop Them? |
Ik-Kyung Jang |
Apr. 21. 16 |
3033 |
DAPT and Beyond 12 Months: Which One and How Long? |
Freek W.A. Verheugt |
Apr. 21. 16 |
3032 |
Pretreatment with P2Y12 Inhibitors in NSTE-ACS: Selective vs. Routine? |
Roxana Mehran |
Apr. 21. 16 |
3031 |
Left Main Case: Complex Trifurcation |
Afzalur Rahman |
Apr. 21. 16 |
3030 |
Left Main Stent Technique and Decision Making: What We Have Learned from the DELTA Registry |
Alaide Chieffo |
Apr. 21. 16 |